Universe · entity
ORBIMED ADVISORS LLC
Institutional manager (13F) · CIK 1055951
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $4.0B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | EDGEWISE THERAPEUTICS INC | $489M | 15,518,492 |
| 2 | ENLIVEN THERAPEUTICS INC | $312M | 7,959,538 |
| 3 | ELI LILLY & CO | $218M | 236,800 |
| 4 | SINOVAC BIOTECH LTD | $184M | 2,718,735 |
| 5 | BOSTON SCIENTIFIC CORP | $149M | 2,382,100 |
| 6 | SIONNA THERAPEUTICS INC | $142M | 3,530,702 |
| 7 | ASTRAZENECA PLC | $132M | 670,200 |
| 8 | MYRIAD GENETICS INC | $123M | 125,000,000 |
| 9 | MBX BIOSCIENCES INC | $109M | 3,637,887 |
| 10 | CORVUS PHARMACEUTICALS INC | $105M | 7,165,006 |
| 11 | ARGENX SE | $100M | 136,900 |
| 12 | EDWARDS LIFESCIENCES CORP | $99M | 1,230,600 |
| 13 | INTUITIVE SURGICAL INC | $96M | 208,700 |
| 14 | COMPASS THERAPEUTICS INC | $81M | 15,219,994 |
| 15 | MERCK & CO INC | $80M | 663,400 |
| 16 | STRUCTURE THERAPEUTICS INC | $71M | 1,475,403 |
| 17 | ARRIVENT BIOPHARMA INC | $70M | 3,027,328 |
| 18 | DISC MEDICINE INC | $68M | 1,067,550 |
| 19 | ARS PHARMACEUTICALS INC | $67M | 8,288,510 |
| 20 | CG ONCOLOGY INC | $64M | 948,267 |
| 21 | XENON PHARMACEUTICALS INC | $62M | 1,059,971 |
| 22 | STRYKER CORPORATION | $60M | 182,500 |
| 23 | BRISTOL-MYERS SQUIBB CO | $56M | 925,000 |
| 24 | MINERALYS THERAPEUTICS INC | $56M | 2,052,900 |
| 25 | PRAXIS PRECISION MEDICINES I | $56M | 172,500 |
| 26 | PFIZER INC | $55M | 1,946,500 |
| 27 | DYNE THERAPEUTICS INC | $53M | 2,917,884 |
| 28 | NATERA INC | $52M | 262,000 |
| 29 | ABIVAX SA | $52M | 465,700 |
| 30 | UPSTREAM BIO INC | $51M | 5,693,589 |
| 31 | DANAHER CORP DEL | $50M | 265,800 |
| 32 | CARIS LIFE SCIENCES INC | $50M | 2,806,811 |
| 33 | AVITA MEDICAL INC | $43M | 41,044,895 |
| 34 | ASCENDIS PHARMA A/S | $42M | 181,977 |
| 35 | SHATTUCK LABS INC | $41M | 6,306,127 |
| 36 | GUARDANT HEALTH INC | $40M | 435,200 |
| 37 | ALNYLAM PHARMACEUTICALS INC | $39M | 119,000 |
| 38 | PRELUDE THERAPEUTICS INC | $37M | 10,909,256 |
| 39 | CRINETICS PHARMACEUTICALS IN | $36M | 999,000 |
| 40 | AXSOME THERAPEUTICS INC. | $36M | 213,921 |
| 41 | UNIQURE NV | $35M | 2,136,149 |
| 42 | ORIC PHARMACEUTICALS INC | $34M | 2,693,929 |
| 43 | ELEVANCE HEALTH INC FORMERLY | $34M | 114,700 |
| 44 | RELMADA THERAPEUTICS INC | $33M | 4,715,864 |
| 45 | FORTE BIOSCIENCES INC | $31M | 1,196,955 |
| 46 | TREVI THERAPEUTICS INC | $29M | 2,454,400 |
| 47 | ESPERION THERAPEUTICS INC NE | $29M | 10,570,300 |
| 48 | NEUROPACE INC | $28M | 2,096,527 |
| 49 | RHYTHM PHARMACEUTICALS INC | $27M | 314,100 |
| 50 | THERMO FISHER SCIENTIFIC INC | $23M | 46,500 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.